Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

AD1 Holdings - Results of Non-Renounceable Entitlement Offer (ASX:AD1)

Melbourne, Australia, 12 May 2023: AD1 Holdings Limited (‘AD1’ or the ‘Company’) (ASX: AD1), announces the results of the Entitlement Offer announced on 30 March 2...read more

Altech Batteries - Two 60KWh Battery Pack Prototypes in Production (ASX:ATC)

Highlights Final market product prototype under fabrication - 60 KWh (ABS60) battery pack Produced at the Fraunhofer IKTS facility in Hermsdorf, Germany 60 KWh battery pack des...read more

Arovella's OroMist R&D facility closure completed (ASX:ALA)

Highlights: Perth-based R&D facility closure has been completed Closure reduces expenditure by approximately $1.5m per annum Part of Arovella’s continued focus on its...read more

Altech Batteries - Quarterly Activities/Appendix 5B Cash Flow Report (ASX:ATC)

Change of Company Name to Altech Batteries Limited Resolution was approved by shareholders at the General Meeting held on 21 February 2023 Resolution received overwhelming su...read more

AD1 Holdings - Extension to Right Issue Closing Date (ASX:AD1)

Melbourne, Australia, 26 April 2023: AD1 Holdings Limited (‘AD1’, the ‘Company’ or the ‘Group’) (ASX: AD1), refers to its a non-renounceable pro-rata rights ...read more

Arovella Therapeutics - Response to ASX Query (ASX:ALA)

For more information, download the attached PDF.

AD1 Holdings - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:AD1)

Melbourne, Australia, 26 April 2023: AD1 Holdings Limited (‘AD1’, the ‘Company’ or the ‘Group’) (ASX:AD1), a technology company with a growing portfolio of market...read more

Arovella Therapeutics - Quarterly Appendix 4C and Activities Report (ASX:ALA)

MELBOURNE, AUSTRALIA 24 April 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treatme...read more

Arovella Therapeutics - Response to ASX Aware Query (ASX:ALA)

Dear Sean Response to Aware Query Arovella Therapeutics Limited (ASX:ALA) (“Arovella” or “the Company”) refers to your Aware Query dated 17 April 2023 (“Aware Que...read more

Arovella Therapeutics - ALA-101 confers survival benefit in leukemia model (ASX:ALA)

-- Arovella has presented new data at the American Association for Cancer Research (AACR) Annual Meeting for CAR19-iNKT cells produced using a new 3rd-generation lentiviral vector as planned for cli...read more

Arovella Therapeutics - Response to ASX Price Query (ASX:ALA)

Response to Price Query Arovella Therapeutics Limited (ASX:ALA) (“Arovella” or “the Company”) refers to your Price Query dated 14 April 2023 and provides the followin...read more

Altech - Progress Update Silumina Anodes Pilot Plant (ASX:ATC)

Highlights Significant progress and according to plan Front end wet circuit complete Commissioning underway of wet circuit On site laboratory completed and being commission...read more

AD1 Holdings - Despatch of Entitlement Offer Documents (ASX:AD1)

Melbourne, Australia, 11 April 2023: AD1 Holdings Limited (‘AD1’ or the ‘Company’) (ASX: AD1), is pleased to announce the despatch of the Offer Booklet and personalised Entit...read more

AD1 Holdings - Notification to ineligible shareholders of Entitlement Offer (ASX:AD1)

To view the notification, download the attached PDF.

Altech Batteries - Presentation Future Facing Commodities Conference (ASX:ATC)

To view the presentation, download the attached PDF.

Viewing: 121 - 135 of 200 Previous | Next